Clinical trial
Stem Cell Transplantation With or Without Rituximab in Treating Patients With…
NCT00052923 · Eastern Cooperative Oncology Group, Other · Completed
Key facts
| NCT number | NCT00052923 |
|---|---|
| Title | Stem Cell Transplantation With or Without Rituximab in Treating Patients With Relapsed or Progressive B-Cell Diffuse Large Cell Lymphoma |
| Official title | Randomized Phase III Trial Of Rituximab (NSC #687451) And Autologous Stem Cell Transplantation For B Cell Diffuse Large Cell Lymphoma |
| Lead sponsor | Eastern Cooperative Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH Cancer and Leukemia Group B |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Lymphoma |
| Intervention type | Biological, Drug, Procedure, Radiation |
| Interventions | filgrastim, rituximab, carmustine, cyclophosphamide, etoposide, peripheral blood stem cell transplantation, radiation therapy |
| Enrollment | 427 |
| Start date | Mar 1, 2003 |
| Primary completion | Jun 1, 2006 |
| First posted | Jan 27, 2003 |
| Last update posted | Feb 9, 2009 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: